| Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito, S Badrinath, ... Science 359 (6383), 1537-1542, 2018 | 396 | 2018 |
| A facile approach to enhance antigen response for personalized cancer vaccination AW Li, MC Sobral, S Badrinath, Y Choi, A Graveline, AG Stafford, ... Nature materials 17 (6), 528-534, 2018 | 349 | 2018 |
| Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB FL Wilkinson, RJ Holley, KJ Langford-Smith, S Badrinath, A Liao, ... PloS one 7 (4), e35787, 2012 | 195 | 2012 |
| A vaccine targeting resistant tumours by dual T cell plus NK cell attack S Badrinath, MO Dellacherie, A Li, S Zheng, X Zhang, M Sobral, ... Nature 606 (7916), 992-998, 2022 | 88 | 2022 |
| Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B* 44 allotypes S Badrinath, P Saunders, T Huyton, S Aufderbeck, O Hiller, R Blasczyk, ... Haematologica 97 (1), 98, 2012 | 36 | 2012 |
| Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B* 44: 02P C Bade-Doeding, P Cano, T Huyton, S Badrinath, B Eiz-Vesper, O Hiller, ... Human Immunology 72 (11), 1039-1044, 2011 | 31 | 2011 |
| Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells ANR Cartwright, S Suo, S Badrinath, S Kumar, J Melms, A Luoma, ... Cancer immunology research 9 (4), 470-485, 2021 | 21 | 2021 |
| A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA‐A24 … S Badrinath, H Kunze-Schumacher, R Blasczyk, T Huyton, ... Journal of Immunology Research 2014 (1), 298145, 2014 | 16 | 2014 |
| Position 45 influences the peptide binding motif of HLA-B* 44: 08 S Badrinath, T Huyton, H Schumacher, R Blasczyk, C Bade-Doeding Immunogenetics 64, 245-249, 2012 | 12 | 2012 |
| Differential impact of HLA-B∗ 44 allelic mismaches at position 156 on peptide binding specificities and T-cell diversity S Badrinath, T Huyton, H Kunze-Schumacher, HA Elsner, R Blasczyk, ... Journal of Stem Cell Research & Therapy 4 (4), 2014 | 5 | 2014 |
| Non-expression of HLA-C* 07: 55N is caused by a premature stop codon in exon 3. S Badrinath, R Blasczyk, C Bade-Doeding Tissue antigens 79 (2), 2012 | 4 | 2012 |
| HLA Class I Polymorphism and Tapasin Dependency S Badrinath, T Huyton, R Blasczyk, C Bade-Doeding HLA and Associated Important Diseases, 2014 | 1 | 2014 |
| EVASION OF LOADING COMPLEX AND PRESENTATION OF NON-CANONICAL PEPTIDES BY HLA-E IMPACTS NKG2-MEDIATED CELLULAR FUNCTION T Kraemer, H Schumacher, T Huyton, S Badrinath, S Moneer, R Blasczyk, ... Tissue Antigens 81 (5), 264-265, 2013 | 1 | 2013 |
| Composición de vacuna que comprende el dominio alfa 3 de mica/b (div. 2018-350) S Badrinath, K Wucherpfennig | | 2023 |
| Vaccination with mica/b alpha 3 domain for the treatment of cancer KW Wucherpfennig, S Badrinath US Patent App. 17/180,183, 2021 | | 2021 |
| Vaccination with MICA/B alpha 3 domain for the treatment of cancer KW Wucherpfennig, S Badrinath US Patent 10,993,971, 2021 | | 2021 |
| Vaccination with mica/b alpha 3 domain for the treatment of cancer S Badrinath, K Wucherpfennig | | 2019 |
| Vacunación con el dominio alfa 3 de mica/b para el tratamiento del cáncer K Wucherpfennig, S Badrinath | | 2018 |
| Development of Epitope-Focused Tumor Vaccine to Prevent Escape from Immune Surveillance by the NKG2D Pathway S Badrinath, Dana-Farber Cancer Institute Boston United States | | 2017 |
| Vaccination with mica/b alpha 3 domain for the treatment of cancer K Wucherpfennig, S Badrinath | | 2017 |
